X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Patients showcase longer, healthier lives in new “From Hope to Cures” ads

By Ieva M. Augstums  |    September 6, 2016
For Ed, a longer life meant more time with family, friends and his dog, BearBear. When he was diagnosed with colon cancer, he underwent six weeks of radiation, seven months of chemotherapy and 10...   Read More

Medicare Monday: Concerns still abound about Part B proposal

By Allyson Funk  |    August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...   Read More

Celebrating diversity in the biopharmaceutical industry

By Andrew Powaleny  |    June 30, 2016
At PhRMA, we often talk about the complexity of developing innovative medicines. Critical to researching new medicines is a workforce that combines sheer brainpower with a level of perseverance...   Read More

Science of Hope: Incorporating the patient perspective

By Andrew Powaleny  |    June 29, 2016
For many of America’s biopharmaceutical researchers and scientists, seeing the positive effects of their work on the lives of patients is what encourages them to keep striving. Dr. Al Sandrock,...   Read More

America’s biopharmaceutical researchers advance the science of hope in new “From Hope to Cures” ads

By Ieva M. Augstums  |    June 14, 2016
Jen and Yingzi are in the problem-solving business. Every day, they tackle one of the toughest health care problems: cancer. While many others like them across the biopharmaceutical industry work...   Read More

Why incorporating patients’ perspectives matters

By Andrew Powaleny  |    June 10, 2016
America’s biopharmaceutical research companies have long been dedicated to researching and developing new medicines that enable patients to live longer, healthier lives. Patients’ voices are...   Read More

Stopping opioid abuse

By Anne McDonald Pritchett, PhD  |    May 6, 2016
According to the U.S. Centers for Disease Control and Prevention (CDC), more than 14,000 people died from overdoses involving opioids in 2014—a four-fold increase since 2009. The agency has...   Read More

Matt and Jamie share their stories in new “From Hope to Cures” ads

By Ieva M. Augstums  |    April 18, 2016
For Matt, today is a great day to be alive. And if you ask him why today is possible for him and why tomorrow is possible, too, he will tell you: Innovative medicines saved his life. When he was...   Read More

A voice for patients

By Guest Contributor  |    April 11, 2016
Dr. Michael Rosenblatt, Executive Vice President and Chief Medical Officer - Merck  I didn’t grow up thinking I wanted to become a chief medical officer (CMO), but at a young age, my love of...   Read More

New PhRMA Report: Medicines in development offer hope for osteoporosis patients and families

By Ieva M. Augstums  |    March 7, 2016
Americans are living longer lives, and our aging population is growing. That’s exciting news – but that also means more and more Americans are at risk of a broken bone as a result of osteoporosis...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates